Volume 5 -Issue 2 patients with working functional status. As expected, TB co-infected clients also had higher odds of experiencing treatment failure [AHR=3.06; 95% CI: (1.72 ± 5.44)]. The study further showed that patients who developed TB after ART initiation had higher odds to experience treatment failure as compared to their counter parts [AHR=4.35; 95% CI: (1.99 ± 9.54]. Having other opportunistic infections during ART initiation was also found to be associated with higher odds of experiencing treatment failure [AHR=7.0, 95% CI: (3.19 ± 15.37)]. Having fair [AHR=4.99 95% CI: (1.90 ± 13.13)] and poor drug adherence [AHR=2.56; 95% CI: (1.12 ± 5.86)] were significantly associated with higher odds of treatment failure as compared to clients with good adherence.
Introduction
Acquired Immuno Deficiency Syndrome (AIDS) continue to be a major global public health concern. There are an estimated 1.3 million people living with in Zimbabwe and 1,100,000 million are estimated to be on Antiretroviral Therapy (ART) by 2018, which translates to over 80% ART coverage [1] . This study explores the factors associated with ART outcomes among adult (15+) persons living with HIV in Zimbabwe.
A synopsis from literature on the subject
Below is a summary of the factors from prior studies across the globe.
Factors associated with treatment failure: Several studies have explored the factors associated with ART outcomes across the globe. The United States' Department of Health and Human Services (2013) reported that treatment failure may occur in PLHIV due to various risk factors. These include poor adherence to treatment, poor absorption of ARVs, previous treatment failure, drug resistance, comorbidities, drug toxicity and drug interactions, poor health prior to initiation of ART, as well as substance abuse (e.g. tobacco smoking or excessive alcohol consumption) leading to poor adherence. Other studies [2] [3] [4] also seem to suggest that other factors such as advanced HIV disease, gender, ARV regimens low baseline CD4, age, and long periods on ART are strongly associated with treatment failure.
A study by Haile, et al. [5] investigated the predictors of treatment failure among adult ART clients in the Bale Zone Hospitals, South Eastern Ethiopia. The study used a retrospective cohort study from four hospitals of Bale zone. The study results showed that male ART clients were more likely to experience treatment failure as compared to females [AHR=4.49; 95% CI: (2.61 ± 7.73)]. In addition, lower CD4 count (<100 m 3 /dl) at initiation of ART was found to be significantly associated with higher odds of treatment failure [AHR=3.79; 95% CI: (2.46 ± 5.84)]. Similarly, bedridden [AHR=5.02; 95% CI: (1.98 ± 12.73)] and ambulatory [AHR=2.12; 95% CI: (1.08 ± 4.07)] patients were more likely to experience treatment failure as compared to
The study results show that approximately 13% of those newly initiated on ART died during follow-up with 56% of all deaths occurring within the first three months. From the study, the CD4 count (adjusted hazard ratio of 4.88; 95% confidence interval of 4.36 to 5.46 for <100 cells/mm 3 vs. >350 cells/mm 3 ); functional status (adjusted hazard ratio of 3.05; 95% confidence interval of 2.82 to 3.30 for bed ridden vs. normal), and body weight (adjusted hazard ratio of 3.69; 95% confidence interval of 3.42 to 3.97 for <45 kg vs. >60 kg) were strongly associated with the survival of HIV patients. This study by Ram Bajpai, et al. [6] shares a lot of methodological similarities with the study undertaken by this researcher. This is exemplified by the following: a retrospective design, a relatively long follow up (which however is only half of what my study is looking at), and significantly larger sample size. It is also worth recognizing the narrower confidence intervals in this study (reflective of less variability owing to a large sample, among other factors). However, this study explores only a limited set of outcomes (primarily survival) in comparison to what this study is investigating. Nonetheless, it provides a rich repository for the current study.
Factors associated with immunological failure: Virologic failure remains one of the major ART outcomes for PLHIV on ART. Evidence shows that there is a myriad of factors associated virologic failure. These include, but not limited to the following: hazardous drinking of alcohol which affect adherence to ARVs [7] ; opportunistic infections during ART [8] ; previous exposure to ARVs before initiation of ART; advanced HIV disease (WHO clinical stage 4) [9] ; change of ARVs due to toxicity; and baseline haemoglobin level less than 10g/dl [2] . On the other hand, other studies indicated that sexual orientation of the patient (comparing heterosexual and non-heterosexual); marital and employment status [2] ; patient's residence (whether urban or rural), pre-ART opportunistic infections, co-infection with Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) [3] .
In addition, other studies have also shown that non disclosure of HIV status, history of Tuberculosis (TB), socioeconomic status/class, history of smoking at time of viral load testing, herbal medicine use at the time of viral load testing [2] and co-morbidities are associated with virologic failure.
While the HIV epidemic remains a "gendered one", studies done in Massachusetts General Hospital out-patient HIV clinic in the USA; in Clinicas de Porto of Brazil and in Chiang Mai University Hospital in Thailand showed that male gender was not associated with virologic failure [3] . Similarly, a study done in Nigeria [2] showed that the male gender was not associated with virologic failure. However, a study done in the Americas (Mexico) showed different results i.e., the results showed that the female gender was marginally associated with virologic failure [4] .
Methodology Study design and data sources
This is a retrospective cohort analysis of treatment outcomes. Data were abstracted from the OI/ART patient care booklets for clients initiated on ART between October 2012 and March 2013.
Study population
Site selection: Data were collected from all five MOHCC facilities in Chitungwiza; namely Chitungwiza Central Hospital, Seke North Clinic, Seke South Clinic, St Mary's Clinic and Zengeza Clinic.
Patient inclusion criteria:
All HIV positive clients 15 years and older, who were initiated on ART between the October 2012 and March 2013, at the five ART sites in Chitungwiza, regardless of treatment outcome, were included in the study.
Patient exclusion criteria:
Patients initiated on ART after March 2013 was excluded from the study. Patients without a documented ART initiation date were excluded from the study.
Sample size
The following formula was used to come up with the sample size:
∆= the desired width of the confidence interval
1-∝= confidence level
This implied that the study needed to sample a minimum of 310 OI/ART Patient Care Booklets to generate 95% confidence intervals with +/-2.5% bounds around the proportion of interest. The sample is distributed as follows, per site, using probability proportional to size (as per their ART volume the five health facilities in June 2013) ( Table 1 ).
Data analysis
All analyses were performed using STATA 13 software. Univariate and multivariate regression modelling was used to identify the factors associated with treatment response of ART patients. Data were faced checked for completeness and consistency. Missing data were estimated using imputation techniques. Logistic regression was done to identify the factors associated with patient retention and linear regression was done to identify factors associated with weight gain. Poisson regression model was used to identify factors associated with immunological response. Univariate Cox proportional hazards model was run for covariate and factor variables. Variables for the multivariate Cox proportional hazards model were selected using the Lemeshow Hosmer statistic, all variables with p-value <0.25 from univariate analysis were considered for inclusion in the multivariate model. The proportional hazards assumption was checked using Kaplan Meir curves and verified using the log-rank test statistic. Post estimation diagnosis was also performed to test the adequacy of all the models.
Ethical Considerations
Clearance was sought from the MOHCC Head Office, the Chitungwiza Central Hospital CEO, the Superintendent at CITIMED Chitungwiza Hospital and the Chitungwiza City Health Department. To ensure confidentiality, no personally identifiable information relating to clients, such as patient name or clinic registration, number were collected during chart extraction. All the data was kept by the principal investigator on a personal computer with a passwordprotected login screen.
Results

Demographic characteristics
Three hundred and five (305) respondents were considered in the study. Sixty percent (60%) of the respondents were females. The majority (71%) of the clients attained a secondary level of education.
Name of Health Facility
Proportion Only one percent of both males and females reached tertiary level. In addition, only one percent did not have any level of education. Sixtyfour percent (64%) of the clients were married, 18% were widowed, 10% were divorced and 7% were single. Table 2 shows other demographic characteristics of the respondents. Fifty-eight percent (58%) of the respondents were enrolled through Voluntary Counseling and Testing (VCT). Thirty-seven percent (37%) of the sampled clients were in WHO clinical stage III, see table 3 for more details. Of the total sample, 23% did not have a CD4 count done (42/183 women and 29/122 men).
Sci Forschen
In 2012/13, where point of care CD4 counts was done, ART initiations were restricted to those with a CD4 cell count of 350 cells/µL or less. The exceptions to this rule were pregnant women as well as those who were TB-HIV co-infected regardless of sex. The proportion of those with/without a documented CD4 result was the same for both males and females. The average CD4 count at initiation was 334 cells/µL for females and 289 cells/µL for males.
Factors associated with the observed treatment outcomes
The section below highlights the critical factors associated with the observed outcomes. Table 4 below provides a synopsis of factors associated with retention. As shown in the table 4, females were twice likely to be retained on ART than their male counterparts. Similarly, the odds of being retained in care among clients in WHO Stage II were 3.02 times that of clients in Stage IV. The odds of being retained in care among clients who received Cotrimoxazole were 1.8 times that of clients who did not receive it. Clients under Multi-Month Scripting (MMS) regime were 28% less likely to be retained than those who were not on MMS. Similarly, clients with a university level of education were 73% less likely to be retained in care compared to those with primary education. See table 4 for additional outputs. Table 5 gives a synopsis of the key factors associated with weight gain (the clinical outcome of interest) using a linear regression model. Female patients have extra weight gain compared to male patients, holding other factors constant. Females were 3.72 times likely to gain weight than their male counterparts (1.313 kg; range of 0.347; 2.279 kg). Widows were 96% less likely to gain weight than those who were married. Similarly, PLHIV with no education were 96% less likely to gain weight compared to PLWHA who attended at least primary school. Table 6 below shows the factors associated with positive changes in CD4 count. The IRRs are the incidence rate ratios for the Poisson model which are obtained by exponentiating the Poisson regression coefficient. The IRR is the estimated rate ratio for one-unit increase in CD4 holding other variables constant in this model. If a widowed person living with HIV were to increase their CD4 by one point, his/her rate ratio for CD4 is expected to decrease by a factor of 0.68. This is statistically significant (CI: 0.57-0.81). The picture is the same for single persons (IRR=0.54; CI: 0.36-0.80); received Cotrimoxazole (IRR=0.69; CI: 0.63-0.76); on MMS (IRR=0.77; CI: 0.64-0.92). Clients in WHO stage IV are expected to have a rate of 1.71 times greater for loss in CD4 than clients in stage 1, while holding other variables constant (IRR=1.71; CI:1.48-1.96). Table 7 below details the factors associated with survival. Using the Weibull regression for predictors, the data shows that women were 96% more likely to survive than male (HR=0.04; CI:0.00-0.28). Similarly, those who received Cotrimoxazole were 93% more likely to survive than those who did not (HR=0.07; CI: 0.02-0.24) as shown in table 7 below. PLHIV with no education were dying at a rate that was 60% more than those with some education (HR=0.4; CI: 0.03-5.72), while clients in WHO stage I were dying at a rate that was 96% lower than those in Stage IV (HR=0.04; CI: 0.01- 
Predictors of retention:
Predictors of weight gain:
Predictors of immunological outcomes (CD4):
Predictors of survival:
Conclusion
The study confirms some of the findings from earlier studies in Zimbabwe, albeit with differences on some of the factors deemed 
